Evidence map›Paper›PMID 40778452›Full record

ReviewEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2025

Management of device embolisation during left atrial appendage closure.

Joelle Kefer, Ole De Backer, Adel Aminian, Xavier Freixa, Sergio Berti, Ignacio Cruz-Gonzalez, Lorenz Räber, Nina Wunderlich, Philippe Garot, Jens Erik Nielsen-Kudsk and 1 more

Abstract readReviewVideo-Audio Media
In one paragraph

Review in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joelle KeferDivision of Cardiology, Cliniques universitaires Saint-Luc et Pôle de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
Ole De BackerThe Heart Center, Rigshospitalet, Copenhagen, Denmark.
Adel AminianDivision of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium.
Xavier FreixaCardiology Department, Institut Clinic Cardiovascular, Hospital Clínic de Barcelona, Barcelona, Spain.
Sergio BertiOspedale del Cuore, Fondazione CNR Regione Toscana, Massa, Italy.
Ignacio Cruz-GonzalezDepartment of Cardiology, University Hospital of Salamanca, IBSAL, CIBER-CV, Salamanca, Spain.
Lorenz RäberDepartment of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
Nina WunderlichDepartment of Cardiology, Asklepios Klinik Langen, Langen, Germany.
Philippe GarotInstitut cardiovasculaire Paris Sud (ICPS), Hôpital privé Jacques Cartier, Ramsay Santé, Massy, France.
Jens Erik Nielsen-KudskDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
On Behalf Of The European Left Atrial Appendage Closure Club Elaacc

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Percutaneous left atrial appendage closure (LAAC) is increasingly used as a valuable intervention to prevent cardioembolic stroke among patients with atrial fibrillation who are poor candidates for long-term anticoagulation. The safety of the procedure has significantly improved over time; nevertheless, device embolisation remains a severe complication that still occurs in around 0.1% of cases. Its management must be rapid and effective in order to reduce mortality. The anatomical location of the embolised device dictates the technical approach for retrieval and has a major impact on the clinical outcome of patients. Percutaneous recapture is the main approach in case of an aortic or left atrial embolisation, while emergent surgery should be performed if the device becomes entangled in the mitral apparatus with poor haemodynamics unsolved by transcatheter device mobilisation into the left ventricular (LV) cavity. In cases of LV embolisation and stable haemodynamics, a transfemoral or transseptal retrieval may be attempted. The equipment for retrieval is key to success: all cath labs performing LAAC procedures should be equipped with minimum 16 Fr sheaths, steerable sheaths, single-loop snares and grasping tool devices. This paper includes a summary of the European Left Atrial Appendage Closure Club consensus recommendations for LAAC device embolisation management.

Indexed as

Atrial AppendageAtrial FibrillationCardiac CatheterizationDevice RemovalEmbolismSeptal Occluder DeviceHumansLeft Atrial Appendage ClosureTreatment Outcome

Identifiers

PMID40778452
PMCPMC12319946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.